P Saravanan, WF Chau, N Roberts… - Clinical …, 2002 - search.ebscohost.com
Abstract Summary objective Over 1% of the UK population is receiving thyroid hormone replacement with l-thyroxine (T4). However, many patients complain of persistent lethargy …
P Saravanan, WF Chau, N Roberts, K Vedhara… - Clinical …, 2002 - cir.nii.ac.jp
抄録< jats: title> Summary</jats: title>< jats: p>< jats: bold> objective</jats: bold> Over 1% of the UK population is receiving thyroid hormone replacement with< jats: sc> l</jats: sc> …
P Saravanan, WF Chau, N Roberts, K Vedhara… - Clinical …, 2002 - elibrary.ru
objective Over 1% of the UK population is receiving thyroid hormone replacement with l- thyroxine (T4). However, many patients complain of persistent lethargy and related …
P Saravanan, WF Chau, N Roberts, K Vedhara… - Clinical …, 2002 - europepmc.org
Objective Over 1% of the UK population is receiving thyroid hormone replacement with l- thyroxine (T4). However, many patients complain of persistent lethargy and related …
P Saravanan, WF Chau, N Roberts… - Clinical …, 2002 - orca.cardiff.ac.uk
objective: Over 1% of the UK population is receiving thyroid hormone replacement with l- thyroxine (T4). However, many patients complain of persistent lethargy and related …
P Saravanan, WF Chau, N Roberts… - Clinical …, 2002 - pubmed.ncbi.nlm.nih.gov
Objective Over 1% of the UK population is receiving thyroid hormone replacement with l- thyroxine (T4). However, many patients complain of persistent lethargy and related …
P Saravanan, WF Chau, N Roberts… - Clinical …, 2002 - orca.cardiff.ac.uk
objective: Over 1% of the UK population is receiving thyroid hormone replacement with l- thyroxine (T4). However, many patients complain of persistent lethargy and related …